REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 14th, 2016 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made as of January 15, 2016, by and between Bellicum Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the persons listed on the attached Schedule A who are signatories to this Agreement (collectively, the “Investors”). Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in Section 1.
LEASE AGREEMENTLease Agreement • March 14th, 2016 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • Texas
This Lease Agreement (this “Lease Agreement”) is made and entered into as of the date set forth on the signature page between SHERIDAN HILLS DEVELOPMENTS L.P., a Texas limited partnership, hereinafter referred to as “Landlord”, and BELLICUM PHARMACEUTICALS, INC., a Delaware corporation, hereinafter referred to as “Tenant”:
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 14th, 2016 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • California
THIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made effective as of December 10, 2015 (the “Effective Date”) by and between Agensys, Inc., a California corporation, having an address at 1800 Stewart St., Santa Monica, CA 90404 (“AGENSYS”), and Bellicum Pharmaceuticals, Inc., a Delaware corporation, having an address at 2130 W. Holcombe Blvd #800, Houston, TX 77030 (“BELLICUM”). AGENSYS and BELLICUM are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
